𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of a new effect-site controlled, patient-maintained sedation system in dental patients

✍ Scribed by R. M. Chapman; K. Anderson; J. Green; J. A. Leitch; S. Gambhir; G. N. C. Kenny


Book ID
108628011
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
85 KB
Volume
61
Category
Article
ISSN
0003-2409

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A prospective randomised controlled stud
✍ N. M. Girdler; D. Rynn; J. P. Lyne; K. E. Wilson πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 184 KB

The safety and effectiveness of patient‐controlled propofol sedation was prospectively assessed in 18 healthy, phobic dental patients. Using a randomised, crossover design each patient received two sessions of equivalent dental treatment under patient‐controlled or clinician‐controlled propofol seda

Patients' priorities among treatment eff
✍ Helen M. Sharp; Marcy List; Ellen MacCracken; Kerstin Stenson; Carol Stocking; M πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 3 views

Background. Patients with head and neck cancer may face decisions between surgery or radiation (with or without chemotherapy) which involve significant trade-offs in functional outcomes. This preliminary investigation is designed to examine patients' priorities among the effects of treatments for he

Effects of a new oral hypoglycaemic agen
✍ B. H. R. Wolffenbuttel; L. Nijst; J. P. J. E. Sels; P. P. C. A. Menheere; P. G. πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 396 KB

We have evaluated the effects of repaglinide, a new non-sulphonylurea oral hypoglycaemic agent that has a stimulatory effect on insulin secretion. Forty-four patients with NIDDM, already treated with a sulphonylurea, took part in an open, randomised, group comparison study of 12 weeks duration, duri